Basics of pharmacovigilance

Talk About Quality

IDMP Standards Explained: Importance and Benefits for Clinical Projects

This article explores the importance of IDMP standards in clinical projects and highlights the key benefits they bring to data consistency, regulatory compliance, and global information exchange.

Bala

Read

Drug safety and pharmacovigilance

What are IME listings?

This article provides an overview of Important Medical Event (IME) listings, their development, and their role in pharmacovigilance.

Bala

Read

Drug safety and pharmacovigilance

Compliance for Beginners: Pharmacovigilance

This article simplifies key compliance concepts, highlights practical do’s and don’ts, and provides essential insights to help case processors and newcomers.

Bala

Read

Talk About Quality

A Good case report

High-quality case reports form the backbone of effective pharmacovigilance. This article explores what defines a good case report in pharmacovigilance.

Bala

Read

Exploring Adverse Events

Adverse Drug Reactions: Types and Classifications Explained

In this comprehensive article, we explain the six classifieds of adverse drug reactions types, each accompanied by a brief definition.

Bala

Read

Drug safety and pharmacovigilance

🥶 Adverse Drug Reactions vs Adverse Event: The differences

In this blog, we address the common confusion between adverse reactions and adverse events. We aim to clarify the distinction between these terms that often perplex many individuals. If you are still uncertain about the difference, this blog provides the perfect opportunity to gain clarity and enhance your understanding.

Bala

Read

Drug safety and pharmacovigilance

Subjects in Clinical Studies: Explained

In this comprehensive article, you’ll discover who the key term by subjects in clinical studies. Let’s dive in and explore.

Bala

Read

Drug safety and pharmacovigilance

Adverse Event Reporting: How to Do It Right

This article explains the importance of adverse event reporting to how to further process for effective submission reports to regulatory authorities.

Bala

Read